How to Buy Immunome Stock

Immunome Inc

Immunome, Inc. , a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease.

Immunome stock last closed at $8.00, up 1.14% from the previous day, and has decreased 47.64% in one year. It has overperformed other stocks in the Biotechnology industry by 0.3 percentage points. Immunome stock is currently +55.34% from its 52-week low of $5.15, and -52.41% from its 52-week high of $16.81.

At the moment, there are 86.95M IMNM shares outstanding. The market value of IMNM is $695.61M. In the last 24 hours, 880,100 IMNM shares were traded.

How to Buy Immunome Stock

Not sure how to invest in Immunome stock? Here's how.

  1. Figure out where to buy Immunome stock: You need to pick a stock brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you figure out where to buy Immunome stock.
  2. Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
  3. Deposit funds into your investment account: Choose your payment method and add your details.
  4. Research Immunome stock: The Immunome ticker symbol is IMNM. Is Immunome stock a good investment? Should you buy shares of IMNM? How do IMNM's underlying business fundamentals look? Do top analysts think Immunome is a good buy? Why has IMNM's stock price moved recently? (Hint: Our stock market research tools can help you decide if IMNM is a good stock to buy).
  5. Make your IMNM purchase: Decide if you will purchase IMNM shares at the current market price or use a limit order to purchase IMNM stock at a specific price.
  6. Watch your IMNM position: Create a watchlist to important updates regarding your new investment in Immunome stock.

Step 1: Figure out where to buy Immunome stock

You need an online brokerage account to access the NASDAQ market and buy IMNM stock.

A brokerage account enables you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

We believe that eToro is the best stock brokerage. eToro gives you:

  • Invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
  • Access to global financial markets: From Technology to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
  • Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for a brokerage account

Now that you've picked your brokerage, it's time to fill out some personal info so you can invest in IMNM today.

How to Set Up a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal details to start your new trading account.
  1. Submit your application by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your investment account

Now that you have created your account on the best stock app, your next step is to transfer the money for your investment:

Check out the tutorial below if you need help transferring funds into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Immunome stock

After you have selected the best place to buy Immunome stock, it's absolutely critical to analyze their stock before you invest, so you truly understand the risk as well as the upside.

Immunome quick stats

IMNM Price
$8.00
1w %
8.84%
1y %
-47.64%
5y %
N/A
P/E
-1.6x
P/B
3.84x
P/S
51.95x
PEG
N/A
Revenue
$9.04M
Earnings
-$292.96M
Fore. Rev. Growth
88.63%
Fore. Earn. Growth
N/A
Market Cap
$695.61M
Next Earnings
May 12, 2025
Next Dividend
N/A

Immunome Due Diligence Checks

WallStreetZen was created to help part-time investors do better fundamental analysis.

You can see all of the due diligence checks on IMNM's stock page.

Is IMNM stock undervalued?

You can use a variety of different financial metrics, analyses, models, and charts to gauge IMNM's fair value.

Using relative valuations metrics:

  • IMNM could be undervalued based on its P/B ratio of 3.84x, relative to Biotechnology industry P/B ratio of 4.04x

You can access more valuation analysis on IMNM's stock here.

IMNM Financial Health Summary

Positive Financial Indicators:

  • There are more short-term assets than long-term liabilities on the IMNM balance sheet.
  • There are more short-term assets than short-term liabilities on the IMNM balance sheet.
  • Total IMNM debt is lower than 5 years ago, relative to shareholder equity.
  • IMNM has a low debt to equity ratio of 0.33.
  • IMNM has cash burn of 117967000. It has sufficient cash and short-term investments to cover this for at least one year.

Negative Financial Indicators:

  • IMNM has $217.40M in cash and short term investments. This is not sufficient to cover its annual cash burn of $117.97M.
  • IMNM profit margin has gone down from -761.9% to -3,240.4% in the past year.

Do analysts think it's a good time to buy IMNM stock

Out of 5 Equities analysts who track IMNM, the consensus analyst rating on IMNM is a Strong Buy

It's important to keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.

Latest IMNM Analyst Forecasts

Biren Amin, a bottom 4% analyst from Piper Sandler maintains IMNM with a strong buy rating and lowers their IMNM price target from $23.00 to $21.00, on Nov 14, 2024.

You can dig deeper into what analysts are projecting on the Immunome stock forecast page.

IMNM Technicals

SMA10
6.88
SMA20
6.86
SMA50
8.4
SMA100
9.87
SMA200
11.64
MACD
-0.24
MACD Signal
-0.53
MACD Histogram
0.29
RSI
56.12
Stochastic %K
89.88
Stochastic %D
88.9
StochRSI %K
96.54
StochRSI %D
96.54

Is IMNM Growing Revenue?

Last year, IMNM revenue was $9.04M. In the past one years, IMNM's revenue has grown by -35.5% per year. This was slower than the Biotechnology industry average of 44.31%.

Learn more about IMNM's earnings and revenue performance here.

Who is buying/selling IMNM?

Over the last year, executives and large shareholders at IMNM have bought more shares than they have sold.

Jack Higgins, Chief Scientific Officer of IMNM, was the latest IMNM insider to buy. They bought $7,020.00 worth of IMNM stock on Mar 27, 2025.

Dig into more about who owns IMNM stock here.

Does IMNM provide a stable income stream?

No, Immunome doesn't provide an income stream by paying out dividends.

What do other investors have to say about IMNM?

One of the reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to find out what other traders have to say.

Step 5: Make your IMNM purchase

There are two primary types of orders:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are generally sufficient.
  • Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
    If you want to make sure you're buying or selling at an exact price, place a limit order.

Click the Open Trade button and your broker will execute your order.

If you need additional help with investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Watch your IMNM position

Now that you own some shares in IMNM, you'll want to keep up with your investment.

Put IMNM on a watchlist to get the latest updates about your IMNM stock.

IMNM Feed

How to Buy Stock in Immunome

To summarize, here are the 6 steps to buy Immunome stock:

  1. Figure out where to buy Immunome stock
  2. Sign up for a brokerage account
  3. Deposit funds into your investment account
  4. Research Immunome stock
  5. Make your IMNM purchase
  6. Watch your IMNM position

If you require a brokerage, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to keep an eye on your new investment in Immunome, click below.

NASDAQ: IMNM
$8.00+0.09 (+1.14%)
Updated Apr 21, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: IMNM
$8.00+0.09 (+1.14%)
Updated Apr 21, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Immunome share?

As of Apr 21, 2025, it costs $8.00 to buy one share of Immunome stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $4, you can buy 0.5 shares of IMNM.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Immunome stock?

According to 5 Wall Street analysts who monitor Immunome, their consensus recommendation is to buy Immunome stock.

What is the best way to buy Immunome stock?

One way to place an order for Immunome stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.